Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Submitted by
admin
on December 5, 2013 - 6:45pm
Source:
Forbes
News Tags:
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
Headline:
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Do Not Allow Advertisers to Use My Personal information
